BMI Vaccine

BMI Vaccine is a biotechnology company based in Taiwan that specializes in the development of therapeutic vaccines for chronic diseases. The company utilizes a Virus-Like Particle (VLP) platform to create vaccines that induce the body's own immune system to produce antibodies against endogenous proteins involved in disease progression. Their primary focus areas include metabolic disorders such as obesity and hypertension, as well as age-related conditions like sarcopenia. By targeting proteins like Angiotensin II and Myostatin, BMI Vaccine aims to provide long-term therapeutic effects with fewer administrations compared to traditional small molecule or monoclonal antibody treatments.